National Reference Centre for Staphylococci and Enterococci (NRC), Division of Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institut, Wernigerode Branch, Wernigerode, Germany.
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany and DZIF (German Centre for Infection Research), partner site Bonn-Cologne, Germany.
J Antimicrob Chemother. 2019 Oct 1;74(10):2926-2929. doi: 10.1093/jac/dkz310.
In 2018, EUCAST issued a warning regarding unreliable results of gradient strip tests for confirming vancomycin resistance in enterococci. We compared the performance of various diagnostic standard and confirmatory tests to identify and determine vanB-type vancomycin resistance.
We analysed a collection of vanB-positive Enterococcus faecium isolates (n = 68) with low vancomycin MICs and compared the performance of VITEK® 2 (bioMérieux), broth microdilution and three gradient strip tests from different providers (Oxoid, Liofilchem and bioMérieux). For the latter we compared the standard procedure with a protocol with increased inoculum, a rich agar medium and a longer incubation time ('macromethod').
The sensitivity of VITEK® 2 was 81% compared with 72% for broth microdilution and 61%-63% for the three gradient strip tests using standard conditions. The macromethod substantially improved the performance of all strip tests resulting in a sensitivity of 89%-96% after 48 h of incubation.
We recommend that EUCAST changes the present warning against the general use of MIC strips. When MIC strips are used to either exclude or confirm suspected vancomycin resistance in E. faecium, and a PCR is not available, the macromethod should be employed. For clinically relevant enterococci, where a rapid therapeutic decision is needed, a molecular test (e.g. PCR) should be favoured in order to save time and to further increase sensitivity.
2018 年,EUCAST 发布了一项关于梯度条试验在确认肠球菌万古霉素耐药性方面结果不可靠的警告。我们比较了各种诊断标准和确认试验的性能,以识别和确定 vanB 型万古霉素耐药性。
我们分析了一组 MIC 值较低的 vanB 阳性屎肠球菌分离株(n = 68),并比较了 VITEK® 2(生物梅里埃)、肉汤微量稀释法和来自不同供应商的三种梯度条试验(Oxoid、Liofilchem 和生物梅里埃)的性能。对于后者,我们比较了标准程序与增加接种物、富含琼脂培养基和更长孵育时间的方案(宏方法)。
VITEK® 2 的灵敏度为 81%,而肉汤微量稀释法为 72%,三种梯度条试验在标准条件下的灵敏度为 61%-63%。宏方法显著提高了所有条试验的性能,在孵育 48 小时后,灵敏度达到 89%-96%。
我们建议 EUCAST 改变目前禁止普遍使用 MIC 条的警告。当 MIC 条用于排除或确认屎肠球菌中疑似万古霉素耐药性,并且无法进行 PCR 时,应采用宏方法。对于需要快速治疗决策的临床相关肠球菌,应优先采用分子检测(例如 PCR),以节省时间并进一步提高灵敏度。